Clinical Trial

Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Humalog®

Completed Phase 1
View on ClinicalTrials.gov →
Summary
Study to demonstrate pharmacokinetic and pharmacodynamic similarity between NKF-INS(L), US-Humalog®, and EU-Humalog®
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-09-03; most recent amendment 2026-03-04.
Status change: Recruiting → Completed 2026-03-04
Status change: Not Yet Recruiting → Recruiting 2025-11-14
Trial Details
NCT Number NCT07165652
Lead Sponsor Xentria, Inc.
Conditions Healthy Male Adult Volunteers
Enrollment 54 participants
Start Date 2025-10-13
Primary Completion 2026-03-02 (estimated)
Study Completion 2026-03-02 (estimated)
Updated on ClinicalTrials.gov 2026-03-06